Rapport Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
99 High St Ste 2100, Boston, Massachuset...Phone Number
(857) 321-8020Website
www.rapportrx.comRevenue
$20 MillionStock Symbol
RAPPIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
2
About Rapport Therapeutics
Rapport Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2022 and headquartered in Boston, Massachusetts, with additional operations in San Diego, California. The company is dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders. Rapport's proprietary RAP technology platform targets receptor-associated proteins (RAPs) to precisely modulate disease-driving neurocircuits, aiming to overcome the limitations of existing neuromedicines that act broadly throughout the nervous system. The company's lead program, RAP-219, is an investigational small molecule being developed for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additional discovery-stage programs target chronic pain and hearing disorders. Rapport was conceptualized through a partnership between Third Rock Ventures and Johnson & Johnson Innovation and completed its initial public offering inRead more
Rapport Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rapport Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Rapport Therapeutics is spiking on competitors!
Check if Rapport Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Rapport Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Rapport Therapeutics launches new products
Funding: Get notified immidiatlly once Rapport Therapeutics has new funding data
Earning: See what the market has to say on Rapport Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Rapport Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Rapport Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Rapport Therapeutics
Find more new buyers
Compare Similar Companies to Rapport Therapeutics
Compare insights from companies similar to Rapport Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rapport Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Rapport Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rapport Therapeutics.
Rapport Therapeutics financials insights
Gather financial insights about Rapport Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$100M
Series B
$150M
2024
Stock Offering
$174M
Rapport Therapeutics Tech Stack
A closer look at the technologies used by Rapport Therapeutics
Most Recent Scoops
Person-Based
Share Placement, Finance
Person-Based
Stake & Stock Ownership, Finance
Person-Based
Events, Proof of Concept (POC)
Person-Based
Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Rapport Therapeutics News & Media
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
This clinical-stage biotech focused on CNS disorders reported a notable insider sale amid a year of exceptional stock appreciation.Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare ConferenceRapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
Phase 2a follow-up period data for RAP-219 in focal onset seizures (FOS) demonstrated sustained seizure reduction, including a 90% median reduction in clinical seizures over baseline in weeks 9-12Rapport Insider Sells $17.2 Million as Stock Surges 230% in a Year and Phase 3 Trials Near
This Boston-based biotech innovator in CNS disorders just reported significant insider selling amid a year of standout stock gains.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rapport Therapeutics
Sign Up For FreeTo access detailed company insights
Rapport Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2022 and headquartered in Boston, Massachusetts, with additional operations in San Diego, California. The company is dedicated to the discovery and development of small molecule precision medicines for patients with neurological and psychiatric disorders. Rapport's prop... Read More
